Admedus will not need capital raising. They are making their own. Can't wait to see the quarterly numbers soon.
- Forums
- ASX - By Stock
- Ann: Admedus announces further data from HSV-2 Trial
Admedus will not need capital raising. They are making their...
-
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.50 |
Change
0.250(1.75%) |
Mkt cap ! $318.1M |
Open | High | Low | Value | Volume |
$15.00 | $15.23 | $14.05 | $173.6K | 11.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 70 | $14.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.69 | 80 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 248 | 14.400 |
1 | 38 | 14.260 |
1 | 714 | 14.000 |
1 | 215 | 13.950 |
1 | 1000 | 13.900 |
Price($) | Vol. | No. |
---|---|---|
14.690 | 80 | 1 |
14.700 | 21 | 1 |
14.770 | 19 | 1 |
14.890 | 68 | 1 |
15.500 | 44 | 1 |
Last trade - 14.59pm 13/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online